TMCnet News
BUYINS.NET: GILD, FDP, MYGN, CETV, NVDA, MOLX, Expected to Trade Lower After Bearish Insider Trading(M2 PressWIRE Via Acquire Media NewsEdge) BUYINS.NET / http://www.squeezetrigger.com is monitoring top insider trading patterns and these stocks are the most likely to trade Lower in the next 6 months. GILEAD SCIENCES, INC. (NASDAQ:GILD), FRESH DEL MONTE PRODUCE INC (NYSE:FDP), MYRIAD GENETICS INC (NASDAQ:MYGN), CENTRAL EUROPEAN MEDIA ENTERPRISES LTD (NASDAQ:CETV), NVIDIA CORPORATION (NASDAQ:NVDA), MOLEX INCORPORATED (NASDAQ:MOLX) are all expected to go Lower as Sell signals have been generated by top insider trading patterns. The most important data elements considered when performing insider analysis are: Insiders Track Record - An insiders track record is best summarized by the Insider Score which ranges from 1 (least predictive) to 100 (most predictive) based on prior trading performance. In addition, the actual returns following the insiders prior trades are included to determine the potential magnitude of future returns. Insiders Role - Trades by higher-level insiders are generally more predictive than trades by lower level insiders. Higher-level insiders to include Chairman (CB), Chief Executive Officer (CEO), President (P), Chief Financial Officer (CFO), and Vice Chairman (VC). The chart below displays the stocks expected to go Lower along with the insider name, position, predictive insider score, 6 month expected return and number of trading decisions included in the score. Symbol Company Name Insider Name Role Shares Insider Score Avg 6 Month Return # of Dec. GILD GILEAD SCIENCES, INC. Metza-Anderson, M Kristen O 5,500 94 -11.6% 10 FDP FRESH DEL MONTE PRODUCE INC Abu, Ghazaleh Amir D 128,568 82 -10.5% 14 MYGN MYRIAD GENETICS INC Evans, James S CFO 10,000 79 -14.9% 7 CETV CENTRAL EUROPEAN MEDIA ENTERPRISES LTD Sarbu, Adrian CEO 50,000 76 -2.7% 7 NVDA NVIDIA CORPORATION Huang, Jen Hsun CEO 190,909 91 -10.3% 43 MOLX MOLEX INCORPORATED Slark, Martin P CEO 20,233 76 -0.6% 17 The insider buying report presents recent insider purchases, reported on Forms 3, 4, and 5 filed with the SEC. The transactions are aggregated to a 'decision' level which simplifies the data analysis. A decision is a grouping of buying or selling by an individual at the specified company. GILEAD SCIENCES, INC. (NASDAQ:GILD) - Gilead Sciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of life threatening diseases worldwide. Its products include Atripla, Truvada, Viread, Emtriva for the treatment of human immunodeficiency virus infection in adults; Hepsera, an oral formulation for the treatment of chronic hepatitis B; AmBisome, a amphotericin B liposome injection to treat invasive fungal infections; Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa for the treatment of chronic angina; Vistide, an antiviral medication for the treatment of cytomegalovirus retinitis in patients with AIDS; and Cayston, an inhaled antibiotic used as a treatment to enhance respiratory systems. The companys products also comprise Tamiflu, an oral antiviral for the treatment and prevention of influenza A and B; Macugen, an intravitreal injection for the treatment of neovascular age-related macular degeneration; and Lexiscan/Rapiscan, an injection used as a pharmacologic stress agent in radionuclide myocardial perfusion imaging. Its products under the Phase III clinical trials consist of Cobicistat, a pharmacoenhancer that is under evaluation as a boosting agent for HIV medicines; Elvitegravir, an oral integrase inhibitor being evaluated as part of combination therapy for HIV; Integrase Single-Tablet, a Quad regimen of elvitegravir, cobicistat, tenofovir disoproxil fumarate, and emtricitabine for the treatment of HIV/AIDS in treatment-naive patients; and Aztreonam for inhalation solution for the treatment of cystic fibrosis patients with Pseudomonas aeruginosa. The companys Phase II clinical trials products comprise Cicletanine, Ranolazine, and Aztreonam, as well as GS 9190, GS 9256, and GS 9451. Its Phase I clinical trial products include GS 7340, GS 5885, GS 6620, GS 9620, and GS 6624. The company was founded in 1987 and is headquartered in Foster City, California. FRESH DEL MONTE PRODUCE INC (NYSE:FDP) - Fresh Del Monte Produce Inc., together with its subsidiaries, produces, transports, sources, markets, and distributes fresh and fresh-cut fruit and vegetables worldwide. It also offers prepared fruit and vegetables, juices, beverages, and snacks. The company provides various fresh-cut fruit products, including pineapple, melons, grapes, citrus, apples, mango, pears, peaches, plums, nectarines, cherries, apricots, avocados, and kiwi; other fruit products comprising strawberries and plantains; and fresh-cut vegetable products primarily consisting of potatoes, onions, bell peppers, and cucumbers, as well as prepared salads, such as coleslaw and potato salad. In addition, Fresh Del engages in ocean freight; the manufacture of plastics and box products comprising bins, trays, bags, and boxes; growing grains on leased farms, including soybean, wheat, and rice; and the poultry farming businesses, as well as owns and operates grain silos for the storage of grains. The company markets and distributes its products to retail stores, foodservice operators, food clubs, wholesalers, and distributors. It offers its fresh produce under the DEL MONTE, UTC, and Rosy names; and prepared fruits and vegetables, juices, beverages, and snacks under the DEL MONTE, Fruit Express, Just Juice, and Fruitini names. The company was founded in 1886 and is based in George Town, Cayman Islands. MYRIAD GENETICS INC (NASDAQ:MYGN) - Myriad Genetics, Inc., a molecular diagnostic company, focuses on the development and marketing of novel predictive medicine, personalized medicine, and prognostic medicine products. The company markets BRACAnalys for the treatment of hereditary breast and ovarian cancer; COLARIS molecular for hereditary colorectal and uterine cancer; COLARIS AP for the treatment of hereditary colon cancer; and MELARIS to treat hereditary melanoma. It also offers TheraGuide 5-FU for chemotherapy toxicity to 5-FU; PREZEON that assess PTEN status for disease progression and drug response; OnDose, a personalized medicine product to measure chemotherapy exposure to 5-FU; Prolaris to treat prostate cancer; and Panexia for the treatment of pancreatic and related cancer. Myriad Genetics, Inc. was founded in 1991 and is headquartered in Salt Lake City, Utah. CENTRAL EUROPEAN MEDIA ENTERPRISES LTD (NASDAQ:CETV) - Central European Media Enterprises Ltd. (CME) operates as a vertically integrated media company operating broadcast, content, and new media businesses in central and eastern European countries. CMEs television stations in Bulgaria comprise bTV, bTV Cinema, bTV Comedy, bTV Action, and Ring.bg; in Croatia include Nova TV, Doma, and Nova World; in the Czech Republic consist of TV Nova, Nova Cinema, Nova Sport, and MTV Czech; in Romania comprise PRO TV, PRO TV International, Acasa, PRO Cinema, PRO TV Chisinau, Sport.ro, and MTV Romania; in the Slovak Republic include TV Markza and Doma; and in Slovenia consist of POP TV, Kanal A, and POP Brio. The company was founded in 1994 and is based in Hamilton, Bermuda. NVIDIA CORPORATION (NASDAQ:NVDA) - Nvidia Corporation provides visual computing technologies that generate interactive graphics on workstations, personal computers, game consoles, and mobile devices. It operates in four segments: Graphic Processing Unit (GPU), Professional Solutions Business (PSB), Media and Communications Processor (MCP), and Consumer Products Business (CPB). The GPU segment offers GeForce products that support desktop and notebook personal computers, PCs, and plus memory products. The PSB segment provides NVIDIA Quadro professional workstation products and other professional graphics products, including NVIDIA Tesla high-performance computing products used in the manufacturing, entertainment, medical, science, and aerospace industries. This segment also offers RealityServer, which streams interactive and photorealistic 3D applications to Web- connected PCs, laptops, netbooks, or smart phones; Quadro Plex SVS, a visual computing platform for professionals who interact with 3D models and analyze data; and the OptiX ray tracing engine, an application acceleration engine for software developers. The MCP segment provides ION NVIDIA motherboard GPU that addresses the integrated core logic market. The CPB segment offers Tegra mobile products that support tablets and smartbooks, smartphones, personal media players, Internet television, automotive navigation, and other devices. This segment also licenses video game consoles and other digital consumer electronics devices. The company sells its products to original equipment manufacturers, original design manufacturers, add-in-card manufacturers, and system builders operating in the entertainment and consumer, consumer electronics, professional design and visualization, computing, and mobile computing markets. NVIDIA Corporation has a strategic partnership with Glu Mobile, Inc. to deliver gaming experiences to Android-powered tablets and mobile devices. The company was founded in 1993 and is headquartered in Santa Clara, California. MOLEX INCORPORATED (NASDAQ:MOLX) - Molex Incorporated manufactures and sells electronic components worldwide. The company offers micro-miniature connectors, SIM card sockets, keypads, electromechanical subassemblies, and internal antennas and subsystems for telecommunications market; and power, optical, and signal connectors and cables for end-to-end data transfer, linking disk drives, controllers, servers, switches, and storage enclosures for data products market. It also designs and manufactures connectors for home and portable audio, digital still and video cameras, DVD players, and recorders, as well as devices that combine multiple functions in the consumer market, as well as devices that combine multiple functions. In addition, the company manufactures cables, backplanes, power connectors, and integrated products that are found in various products, such as electronic weighing stations, and industrial microscopes and vision systems; interface cards, software for industrial networks, and connectivity solutions; and compact robotic connectors and I/O connectors for servo motors, as well as a range of products for automotive market. Further, it provides connectors and custom integrated systems for diagnostic and therapeutic equipment used in hospitals, including x-ray, magnetic resonance imaging, and dialysis machines. Additionally, the company provides manufacturing services to integrate specific components into a customers product. It sells its products to original equipment manufacturers, contract manufacturers, and distributors. Molex Incorporated was founded in 1938 and is based in Lisle, Illinois. About BUYINS.NET BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include: REGULATORY & COMPLIANCE NEWS Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO INVESTMENTS & TRADING SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports. Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks. Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups. Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks. GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time. Insider Trading tracks all insider trades and selects those insider buys that predict higher moves and insider sales that predict lower moves. DISCLAIMER: BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures. Contact: BUYINS.NET Thomas Ronk 800-715-9999 [email protected] www.buyins.net ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to [email protected])). (c) 2011 M2 COMMUNICATIONS |